Experiments have shown that QCG inhibits prostate cancer cell proliferation by inhibiting the cell cycle in the G0/G1 phase and induces apoptosis by releasing cytochrome c, caspase-3, and poly ADP-ribose polymerase. Here, CYCS is linked to prostate carcinoma.